Canada markets closed

iBio, Inc. (IBIO)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
1.7200-0.0500 (-2.82%)
At close: 04:00PM EDT
1.7300 +0.01 (+0.58%)
After hours: 07:49PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-06-30
2022-06-30
2021-06-30
2020-06-30
Total Revenue
50
0
1,884
2,371
1,638
Cost of Revenue
-
-
216
1,462
703
Gross Profit
-
-
2,167
909
935
Operating Expenses
Research Development
8,141
10,327
9,827
9,989
3,573
Selling General and Administrative
12,642
19,016
21,754
22,031
11,365
Total Operating Expenses
20,783
29,343
31,581
32,020
14,938
Operating Income or Loss
-20,733
-29,343
-29,697
-31,111
-14,003
Interest Expense
112
83
0
2,454
2,466
Total Other Income/Expenses Net
-
-98
7
10,212
10
Income Before Tax
-20,773
-29,311
-29,513
-23,213
-16,444
Income from Continuing Operations
-20,773
-29,311
-29,513
-23,213
-16,444
Net Income
-27,284
-65,010
-50,391
-23,207
-16,439
Net Income available to common shareholders
-27,284
-65,010
-50,391
-23,467
-38,260
Basic EPS
-70.00
-106.20
-115.60
-60.00
-305.00
Diluted EPS
-70.00
-106.20
-115.60
-60.00
-305.00
Basic Average Shares
801.338
612.25
436.05
391.25
125.59
Diluted Average Shares
801.338
612.25
436.05
391.25
125.59